| 英文别名 |
Cedirogant;X6466M4LVP;Cedirogant [INN];Cedirogant [USAN];BDBM292795;US10106501, Example EI-5;US10106501, Example EI-6;WHO 11460;(1-(2,4-Dichloro-3-((7-chloro-5-(trifluoromethyl)-1hindol-1-yl)methyl)benzoyl)piperidin-4-yl)acetic acid;4-Piperidineacetic acid, 1-(2,4-dichloro-3-((7-chloro-5-(trifluoromethyl)-1H-indol-1-yl)methyl)benzoyl)-;D12274;EX-A5810;AKOS040759913;DA-72060;CHEMBL5095174;ABV-157;HY-137434;CS-0138634;UNII-X6466M4LVP;2-(1-(2,4-dichloro-3-((7-chloro-5-(trifluoromethyl)-1H-indol-1-yl)methyl)benzoyl)piperidin-4-yl)acetic acid;F77949;2-[1-[2,4-dichloro-3-[[7-chloro-5-(trifluoromethyl)indol-1-yl]methyl]benzoyl]piperidin-4-yl]acetic acid;Cedirogant [WHO-DD];4-Piperidineacetic acid, 1-[2,4-dichloro-3-[[7-chloro-5-(trifluoromethyl)-1H-indol-1-yl]methyl]benzoyl]-;MS-30038;ABBV-157;2055496-11-0;Cedirogant (USAN/INN);MNEOHCYSHVKLIC-UHFFFAOYSA-N;Cedirogant [USAN:INN];SCHEMBL18299842 |